The therapeutic use of labyrinths
- 作者Maggie Fisher
- 卷第4卷
- 期第1期
- 印刷ISSN1743-1867
- 电子ISSN1557-0665
- 文件大小587.78KB
- 发表时间2003
- DOI10.1002/shi.139
- 页码30-34
Targeting Norovirus Infection—Multivalent Entry Inhibitor Design Based on NMR ExperimentsDr. Christoph Rademacher; Dr. Julie Guiard; Dr. Pavel I. Kitov; Brigitte Fiege; Dr. Kevin P. Dalton; Prof. Dr. Francisco Parra; Prof. Dr. David R. Bundle; Prof. Dr. Thomas Peters · 2011
Age and the effects of ectDr. Andrew M. Wilkinson; David N. Anderson; Stephen Peters · 1993
“Double-Click” Protocol for Synthesis of Heterobifunctional Multivalent Ligands: Toward a Focused Library of Specific Norovirus InhibitorsDr. Julie Guiard; Brigitte Fiege; Dr. Pavel I. Kitov; Prof. Dr. Thomas Peters; Prof. Dr. David R. Bundle · 2011
Treatment of Junin Virus-Infected Guinea Pigs With Immune Serum: Development of Late Neurological DiseaseDr. Richard H. Kenyon; David E. Green; Dr. Gerald A. Eddy; Clarence J. Peters · 1986
Interical spiking increases 2-deoxy[14C]glucose uptake and c-fos—like reacitivityDr. Adrian Handforth; David M. Finch; Richard Peters; Aiko M. Tan; David M. Treiman · 1994
Hantaan virus infection in suckling mice: Virologic and pathologic correlatesDr. Kelly T. McKee Jr.; Gum Ryong Kim; David E. Green; C. J. Peters · 1985
Metabolism of the third component of complement (C3) in patients with rheumatoid arthritisDr. Arthur Weinstein; Keith Peters; David Brown; Rodney Bluestone · 1972